In order to clarify the role of NF-κB in the glucose fluctuations-mediated inflammasome-involved regulation of myocardial fibrosis, the IKK-2 inhibitor TPCA-1 was applied in this study. This evidence concerns the gene NFKB1 and Myocardial fibrosis.